FBN1 gene mutations in patients with congenital ectopia lentis caused by Marfan syndrome

The prevalence of congenital ectopia lentis is 7–10 cases per 100 000 people. The most common causes of congenital lens displacement are the FBN1 gene mutations that have been found in 25–85 % of patients with this pathology. The aim of the study is to establish the FBN1 gene mutations in patients with congenital lens displacement and in their families. The study group included three families with children and adults suffered from the congenital lens dislocation. The nucleotide sequence of the FBN1 gene was analyzed by direct sequencing. The pathogenicity of the identified mutations was assessed using the Ghent criteria revised in 2010. The mutation c.1884C> G (p.Cys628Trp) in the heterozygous state in the 16th exon of the FBN1 gene was detected in proband 1 and her brother. Proband 2 was found to be a heterozygous career of the mutation c.2461T> A (p.Cys821Ser) in the 21st exon; this mutation was absent in parents and a healthy brother. The mutation c.7851delС (p.Cys2617Trpfs*65) in the heterozygous state in the 64th exon was identified in proband 3 and her mother. In accordance with the revised Ghent classification and the clinical manifestations and molecular genetic studies, Marfan’s syndrome (MS) was diagnosed in all probands and their affected relatives. We detected three pathogenic mutations not previously described in the literature in the 16th, 21st, and 64th exons of the FBN1 gene in patients with congenital ectopia lentis caused by MS. We established the spectrum of clinical manifestations of MS characteristic for the identified mutations.

1. Pobol’-Solonko O. L., Marchenko L. N., Ivanova V. F., Dalidovich A. A. Epidemiology of children’s myopia in Republic of Belarus. Sovremennaya rekonstruktivnaya khirurgiya v oftal’mologii: materialy respublikanskoi nauchnoi konferentsii s mezhdunarodnym uchastiem (13–14 dekabrya 2013 goda, Minsk) [Modern reconstructive surgery in ophthalmology: materials of a republican scientific conference with international participation (December 13–14, 2013, Minsk)]. Minsk, 2013, pp. 231–235 (in Russian).

2. Ermolaev A. V. Sociological substantiation of a set of measures for the prevention of ocular pathology in children (based on materials from Astrakhan). Ph. D. Thesis. Volgograd, 2004. 182 p. (in Russian).

3. Konovalov M. E., Kozhukhov A. A., Zenina M. L., Gorenskii A. A. Surgical treatment of ectopia lens in children. Vestnik Tambovskogo universiteta. Seriya Estestvennye i tekhnicheskie nauki = Tambov University Reports. Series: Natural and Technical Sciences, 2014, vol. 19, no. 4, pp. 1149–1151 (in Russian).

4. Grabovetskii V. R., Titarenko A. I., Papanyan S. S. Congenital disorders of the capsule-ligament complex of the eye. Oftal’mologicheskie vedomosti = Ophthalmology journal, 2016, vol. 9, no. 2, pp. 45–51 (in Russian).

5. Overwater E., Floor K., van Beek D., de Boer K., van Dijk T., Hilhorst-Hofstee Y. [et al.]. NGS panel analysis in 24 ectopia lentis patients; a clinically relevant test with a high diagnostic yield. European Journal of Medical Genetics, 2017, vol. 60, no. 9, pp. 465–473. https://doi.org/10.1016/j.ejmg.2017.06.005

6. Li J., Jia X., Li S., Fang S., Guo X. Mutation survey of candidate genes in 40 Chinese patients with congenital ectopia lentis. Molecular Vision, 2014, vol. 20, pp. 1017–1024.

7. Dietz H. C., Cutting G. R., Pyeritz R. E., Maslen C. L., Sakai L. Y., Corson G. M. [et al.]. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 1991, vol. 352, no. 6333, pp. 337–339. https://doi.org/10.1038/352337a0

8. Loeys B. L., Dietz H. C., Braverman A. C., Callewaert B. L., de Backer J., Devereux R. B. [et al.]. The revised Ghent nosology for the Marfan syndrome. Journal of Medical Genetics, 2010, vol. 47, no. 7, pp. 476–485. https://doi.org/10.1136/jmg.2009.072785

9. Aljanabi S. M., Martinez I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Research, 1997, vol. 25, no. 22, pp. 4692–4693. https://doi.org/10.1093/nar/25.22.4692

10. Nijbroek G., Sood S., McIntosh L., Francomano Cl. A., Bull E., Pereira L., Ramirez Fr., Pyeritz R. E., Dietz H. C. Fifteen novel FBNI mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. American Journal of Human Genetics, 1995, vol. 57, no. 1, pp. 8–21.

11. Nemet A. Y., Assia E. I., Apple D. J., Barequet I. S. Current concepts of ocular manifestations in Marfan syndrome. Survey of Ophthalmology, 2006, vol. 51, no. 6, pp. 561–575. https://doi.org/10.1016/j.survophthal.2006.08.008

12. Tinkle B. T., Saal H. M. Health supervision for children with Marfan syndrome. Pediatrics, 2013, vol. 132, no. 4, pp. e1059–e1072. https://doi.org/10.1542/peds.2013-2063

13. Chandra A., Ekwalla V., Child A., Charteris D. Prevalence of ectopia lentis and retinal detachment in Marfan syndrome. Acta Ophthalmologica, 2014, vol. 92, no. 1, pp. e82–e83. https://doi.org/10.1111/aos.12175

14. Esfandiari H., Ansari Sh., Mohammad-Rabei H., Mets M. B. Management strategies of ocular abnormalities in patients with Marfan syndrome: current cerspective. Journal of Ophthalmic and Vision Research, 2019, vol. 14, no. 1, pp. 71– 77. https://doi.org/10.4103/jovr.jovr_29_18.

15. Salchow D. J., Gehle P. Ocular manifestations of Marfan syndrome in children and adolescents. European Journal of Ophthalmology, 2018, vol. 29, no. 1, pp. 38–43. https://doi.org/10.1177/1120672118761333

16. Pashtaev N. P. Classification of lens dislocations, modern treatment tactics. Aktual’nye problemy khirurgii khrustalika, steklovidnogo tela i setchatki: sbornik nauchnykh trudov [Actual problems of surgery of the lens, vitreous body and retina: a collection of scientific papers]. Moscow, 1986, pp. 34–37 (in Russian).

17. Bobrova N. F., Khmaruk A. N., Pashegor T. E. Clinical features and surgical removal of subluxated lenses in Marfan syndrome. Oftal’mologicheskie vedomosti = Ophthalmology journal, 2001, no. 4, pp. 27–33 (in Russian).

18. Kruglova T. A., Egiyan N. S. Our experience with surgery for the dislocated lens and the posterior chamber IOL implantation using the intracapsular ring in children with Marfan syndrome. Rossiiskii obshchenatsional’nyi oftal’mologicheskii forum [Russian national ophthalmological forum], 2018, vol. 1, pp. 73–75 (in Russian).

19. Hoyt C. S., Taylor D. Pediatric ophthalmology and strabismus. 4th ed. London, Elsevier, 2013. 1168 p. (Russ. ed.: Khoit K. S., Teilor D. Detskaya oftal’mologiya. Tom 1. Moskva, Izdatel’stvo Panfilova Publ., 2015. 653 p.).

20. Stuart A. G., Williams A. Marfan’s syndrome and the heart. Archives of Disease in Childhood, 2007, vol. 92, no. 4, pp. 351–356. https://doi.org/10.1136/adc.2006.097469

21. Wozniak-Mielczarek L., Sabiniewicz R., Drezek-Nojowicz M., Nowak R., Gilis-Malinowska N., Mielczarek M., Łabuc A., Waldoch A., Wierzba J. Differences in cardiovascular manifestation of Marfan syndrome between children and adults. Pediatric Cardiology, 2019, vol. 40, no. 2, pp. 393–403. https://doi.org/10.1007/s00246-018-2025-2

22. Aalberts J. J., van Tintelen J. P., Meijboom L. J., Polko A., Jongbloed J. D., van der Wal H. [et al.]. Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome. Gene, 2014, vol. 534, no. 1, pp. 40–43. https://doi.org/10.1016/j.gene.2013.10.033

23. Loeper F., Oosterhof J., van den Dorpel M., van der Linde D., Lu Y., Robertson E., Hambly B., Jeremy R. Ventricularvascular coupling in Marfan and non-Marfan аortopathies. Journal of the American Heart Association, 2016, vol. 5, no. 11, p. e003705. https://doi.org/10.1161/JAHA.116.003705

24. Pepe G., Giusti B., Sticchi E., Abbate R., Gensini G. Fr., Nistri St. Marfan syndrome: current perspectives. Application of Clinical Genetics, 2016, vol. 9, pp. 55–65. https://doi.org/10.2147/TACG.S96233

25. Collod-Béroud G., le Bourdelles S., Ades L., Ala-Kokko L., Booms P., Boxer M. [et al.]. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Human Mutation, 2003, vol. 22, no. 3, pp. 199–208. https://doi.org/10.1002/humu.10249

26. Jensen S. A., Handford P. A. New insights into the structure, assembly and biological roles of 10–12 nm connective tissue microfibrils from fibrillin-1 studies. Biochemical Journal, 2016, vol. 473, no. 7, pp. 827–838. https://doi.org/10.1042/BJ20151108

27. Franken R., Heesterbeek Th. J., de Waard V., Zwinderman A. H., Pals G., Mulder B. J. M., Groenink M. Diagnosis and genetics of Marfan syndrome. Expert Opinion on Orphan Drugs, 2014, vol. 2, no. 10, pp. 1049–1062. https://doi.org/10.1517/21678707.2014.950223

28. Dietz H. C., McIntosh I., Sakai L. Y., Corson G. M., Chalberg S. C., Pyeritz R. E., Francomano C. A. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics, 1993, vol. 17, no. 2, pp. 468–475. https://doi.org/10.1006/geno.1993.1349

29. Schrijver I., Liu W., Odom R., Brenn T., Oefner P., Furthmayr H., Francke U. Premature termination mutations in FBN1: distinct effects on differential allelic expression and on protein and clinical phenotypes. American Journal of Human Genetics, 2002, vol. 71, no. 2, pp. 223–237. https://doi.org/10.1086/341581

30. Comeglio P., Johnson Ph., Arno G., Brice G., Evans A., Aragon-Martin J., Pereira da Silva F., Kiotsekoglou A., Child A. The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193FBN1 mutations. Human Mutation, 2007, vol. 28, no. 9, p. 928. https://doi.org/10.1002/humu.9505

31. Katzke St., Booms P., Tiecke Fr., Palz M., Pletschacher A., Türkmen S. [et al.]. TGGE screening of the entire FBN1 coding sequence in 126 individuals with Marfan syndrome and related fibrillinopathies. Human Mutation, 2002, vol. 20, no. 3, pp. 197–208. https://doi.org/10.1002/humu.10112

32. National Center for Biotechnology Information. ClinVar; [FBN1[gene]]. Available at: https://www.ncbi.nlm.nih.gov/clinvar/?term=FBN1[gene] (accessed 17.10.2019).

33. Robinson D. O., Lin F., Lyon M., Raponi M., Cross E., White H. E., Cox H., Clayton-Smith J., Baralle D. Systematic screening of FBN1 gene unclassified missense variants for splice abnormalities. Clinical Genetics, 2012, vol. 82, no. 3, pp. 223–231. https://doi.org/10.1111/j.1399-0004.2011.01781.x

34. Chen Q.-Q., Wu Y.-A., Huang X.-L., Chen T., Huang Y., Chen F.-L., Chen F.-W. Two novel mutations of FBN1 gene in the patients with MFS among Han population. Hereditas (Beijing), 2010, vol. 32, no. 1, pp. 49–53. https://doi.org/10.3724/sp.j.1005.2010.00049

35. Hung C.-C., Lin S.-Y., Lee C.-N., Cheng H.-Y., Lin S.-P., Chen M.-R. [et al.]. Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome. Annals of Human Genetics, 2009, vol. 73, no. 6, pp. 559–567. https://doi.org/10.1111/j.1469-1809.2009.00545.x

36. Stheneur C., Collod-Béroud G., Faivre L., Buyck J. F., Gouya L., Le Parc J. M. [et al.]. Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. European Journal of Human Genetics, 2009, vol. 17, no. 9, pp. 1121–1128. https://doi.org/10.1038/ejhg.2009.36

37. Turner C. L. S., Emery H., Collins A. L., Howarth R. J., Yearwood C. M., Cross E., Duncan P. J., Bunyan D. J., Harvey J. F., Foulds N. C. Detection of 53 FBN1 mutations (41 novel and 12 recurrent) and genotype–phenotype correlations in 113 unrelated probands referred with Marfan syndrome, or a related fibrillinopathy. American Journal of Medical Genetics. Part A, 2009, vol. 149A, no. 2, pp. 161–170. https://doi.org/10.1002/ajmg.a.32593

38. Collod-Béroud G., Le Bourdelles S., Ades L., Ala-Kokko L., Booms P., Boxer M. [et al.]. Update of the UMD-FBN1 mutation database and creation of an FBN1 polymorphism database. Human Mutation, 2003, vol. 22, no. 3, pp. 199–208. https://doi.org/10.1002/humu.10249

39. Franken R., Groenink M., de Waard V., Feenstra H. M. A., Scholte A. J., van den Berg M. P., Pals G., Zwinderman A. H., Timmermans J., Mulder B. J. M. Genotype impacts survival in Marfan syndrome. European Heart Journal, 2016, vol. 37, no. 43, pp. 3285–3290. https://doi.org/10.1093/eurheartj/ehv739

40. Aburawi E. H., O’Sullivan J. Relation of aortic root dilatation and age in Marfan’s syndrome. European Heart Journal, 2007, vol. 28, no. 3, pp. 376–379. https://doi.org/10.1093/eurheartj/ehl457

41. Lindeman J. H., Matsumura J. S. Pharmacologic management of aneurysms. Circulation Research, 2019, vol. 124, no. 4, pp. 631–646. https://doi.org/10.1161/circresaha.118.312439

42. Hiratzka L. F., Bakris G. L., Beckman J. A., Bersin R. M., Carr V. F., Casey De Jr. [et al.]. ACCF/AHA/AATS/ACR/ ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation, 2010, vol. 121, no. 13, pp. e266–e369. https://doi.org/10.1161/cir.0b013e3181d4739e

43. Arutyunov A. G., Vertinskii E. A., Kozlovskii V. I., Letkovskaya T. A., Luneva E. B., Lysyi Yu. S. Inherited aneurysms and thoracic aortic dissection. Supranational (international) recommendations. Minsk, Professional’nye izdaniya Publ., 2016, p. 56 (in Russian).

44. Franken R., den Hartog A. W., Radonic T., Micha D., Maugeri A., van Dijk F. S. [et al.]. Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome. Circulation: Cardiovascular Genetics, 2015, vol. 8, no. 2, pp. 383–388. https://doi.org/10.1161/CIRCGENETICS.114.000950